1. Home
  2. ALGS vs AAME Comparison

ALGS vs AAME Comparison

Compare ALGS & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALGS
  • AAME
  • Stock Information
  • Founded
  • ALGS 2018
  • AAME 1968
  • Country
  • ALGS United States
  • AAME United States
  • Employees
  • ALGS N/A
  • AAME N/A
  • Industry
  • ALGS Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • ALGS Health Care
  • AAME Finance
  • Exchange
  • ALGS Nasdaq
  • AAME Nasdaq
  • Market Cap
  • ALGS 53.0M
  • AAME 46.3M
  • IPO Year
  • ALGS 2020
  • AAME N/A
  • Fundamental
  • Price
  • ALGS $11.34
  • AAME $3.27
  • Analyst Decision
  • ALGS Strong Buy
  • AAME
  • Analyst Count
  • ALGS 2
  • AAME 0
  • Target Price
  • ALGS $60.00
  • AAME N/A
  • AVG Volume (30 Days)
  • ALGS 74.9K
  • AAME 56.2K
  • Earning Date
  • ALGS 11-05-2025
  • AAME 08-12-2025
  • Dividend Yield
  • ALGS N/A
  • AAME 0.61%
  • EPS Growth
  • ALGS N/A
  • AAME N/A
  • EPS
  • ALGS N/A
  • AAME 0.10
  • Revenue
  • ALGS $3,174,000.00
  • AAME $198,977,000.00
  • Revenue This Year
  • ALGS N/A
  • AAME N/A
  • Revenue Next Year
  • ALGS $28.79
  • AAME N/A
  • P/E Ratio
  • ALGS N/A
  • AAME $31.22
  • Revenue Growth
  • ALGS N/A
  • AAME 6.98
  • 52 Week Low
  • ALGS $3.76
  • AAME $1.25
  • 52 Week High
  • ALGS $46.80
  • AAME $3.71
  • Technical
  • Relative Strength Index (RSI)
  • ALGS 70.84
  • AAME 61.22
  • Support Level
  • ALGS $10.01
  • AAME $3.11
  • Resistance Level
  • ALGS $10.86
  • AAME $3.37
  • Average True Range (ATR)
  • ALGS 0.97
  • AAME 0.28
  • MACD
  • ALGS 0.13
  • AAME -0.03
  • Stochastic Oscillator
  • ALGS 90.81
  • AAME 42.21

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: